Atorvastatin for eradication of Helicobacter pylori

Phase 4

Recruiting

• Conditions: Helicobacter pylori infection.; Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere; B96.81

• Registration Number: IRCT20161205031252N7
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 July 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Age over 18 years
]nfection with Helicobacter pylori
Would like to participate in the study

Exclusion Criteria

Contraindications of Clarithromycin, Amoxicillin, Bismuth, Omeprazole or Atorvastatin

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Eradication of Helicobacter pylori. Timepoint: 4 weeks after intervention. Method of measurement: Stool antigen test.